These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25808574)

  • 21. Possible association of elevated serum collagen type IV level with skin sclerosis in systemic sclerosis.
    Motegi SI; Sekiguchi A; Fujiwara C; Toki S; Ishikawa O
    J Dermatol; 2017 Feb; 44(2):167-172. PubMed ID: 27568491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study.
    Almeida I; Oliveira Gomes A; Lima M; Silva I; Vasconcelos C
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):37-42. PubMed ID: 26885625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
    Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
    Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.
    Yanaba K; Hayashi M; Yoshihara Y; Nakagawa H
    J Dermatol; 2016 Aug; 43(8):954-7. PubMed ID: 26945563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
    Stefanantoni K; Sciarra I; Vasile M; Badagliacca R; Poscia R; Pendolino M; Alessandri C; Vizza CD; Valesini G; Riccieri V
    Reumatismo; 2015 Mar; 66(4):270-6. PubMed ID: 25829187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage.
    Ogawa F; Shimizu K; Hara T; Muroi E; Hasegawa M; Takehara K; Sato S
    Clin Exp Rheumatol; 2008; 26(4):659-62. PubMed ID: 18799101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis.
    Becker H; Willeke P; Schotte H; Domschke W; Gaubitz M
    Clin Rheumatol; 2008 Oct; 27(10):1307-11. PubMed ID: 18618071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum soluble CD40 levels in patients with systemic sclerosis.
    Komura K; Fujimoto M; Matsushita T; Yanaba K; Kodera M; Kawasuji A; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2007 Feb; 34(2):353-8. PubMed ID: 17295440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene.
    Ichimura Y; Asano Y; Hatano M; Tamaki Z; Takekoshi T; Kogure A; Tomita M; Kawashima T; Miyazaki M; Taniguchi T; Takahashi T; Mitsui H; Sugaya M; Yao A; Kinugawa K; Sato S
    Mod Rheumatol; 2011 Oct; 21(5):548-52. PubMed ID: 21547701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
    Miyagawa T; Asano Y; Saigusa R; Hirabayashi M; Yamashita T; Taniguchi T; Takahashi T; Nakamura K; Miura S; Yoshizaki A; Miyagaki T; Sato S
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):753-760. PubMed ID: 30520152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.
    Bosello S; Basile U; De Lorenzis E; Gulli F; Canestrari G; Napodano C; Parisi F; Pocino K; Di Mario C; Tolusso B; Ferraccioli G; Gremese E
    J Clin Pathol; 2018 Jul; 71(7):620-625. PubMed ID: 29447111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis.
    Shirai Y; Okazaki Y; Inoue Y; Tamura Y; Yasuoka H; Takeuchi T; Kuwana M
    Arthritis Rheumatol; 2015 Feb; 67(2):498-507. PubMed ID: 25385504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis.
    Khan K; Xu S; Nihtyanova S; Derrett-Smith E; Abraham D; Denton CP; Ong VH
    Ann Rheum Dis; 2012 Jul; 71(7):1235-42. PubMed ID: 22586157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum soluble OX40 in patients with systemic sclerosis.
    Komura K; Yoshizaki A; Kodera M; Iwata Y; Ogawa F; Shimizu K; Wayaku T; Yukami T; Murata M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2359-62. PubMed ID: 18843780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis.
    Takahashi T; Takahashi T; Ikawa T; Terui H; Takahashi T; Segawa Y; Sumida H; Yoshizaki A; Sato S; Asano Y
    J Dermatol; 2024 Aug; 51(8):1083-1090. PubMed ID: 38619119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.
    Taniguchi T; Miyagawa T; Tamaki Z; Nakamura K; Yamashita T; Saigusa R; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Tada Y; Sugaya M; Kadono T; Sato S; Asano Y
    Arch Dermatol Res; 2017 Dec; 309(10):833-842. PubMed ID: 29038846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased messenger RNA levels of the mesenchymal cadherin-11 in the peripheral blood of systemic sclerosis patients correlate with diffuse skin involvement.
    Christopoulos PF; Bournia VK; Panopoulos S; Vaiopoulos A; Koutsilieris M; Sfikakis PP
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S36-9. PubMed ID: 26121083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis.
    Yanaba K; Asano Y; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2013 Jan; 305(1):17-23. PubMed ID: 23053221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.